Xylotubercidin
| Code | Size | Price |
|---|
| TAR-T35209-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Xylotubercidin is a biochemical.
CAS:
64526-29-0
Formula:
C11H14N4O4
Molecular Weight:
266.257
Purity:
0.98
SMILES:
Nc1ncnc2n(ccc12)[C@@H]1O[C@H](CO)[C@H](O)[C@H]1O
References
De Clercq E, Robins MJ. Xylotubercidin against herpes simplex virus type 2 in mice. Antimicrob Agents Chemother. 1986 Nov;30(5):719-24. PubMed PMID: 3800347; PubMed Central PMCID: PMC176520.
Cass CE, Selner M, Tan TH, Muhs WH, Robins MJ. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin. Cancer Treat Rep. 1982 Feb;66(2):317-26. PubMed PMID: 6976834.
Kawana F, Shigeta S, Hosoya M, Suzuki H, De Clercq E. Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro. Antimicrob Agents Chemother. 1987 Aug;31(8):1225-30. PubMed PMID: 3307618; PubMed Central PMCID: PMC174908.